0.1502
-0.0098
(-6.13%)
At close: January 10 at 4:00:00 PM EST
0.1272
-0.02
(-15.31%)
After hours: January 10 at 6:08:03 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-27,199.9060
-25,173.6390
-19,030.2080
-11,196.4200
-2,750.5700
Investing Cash Flow
-39.6020
-48.9460
-134.2580
-47.7180
-156.7910
Financing Cash Flow
23,144.9900
4,062.4420
35,353.3280
12,784.2120
12,507.8160
End Cash Position
8,592.5230
6,452.5890
27,612.7320
11,423.8700
9,883.7960
Capital Expenditure
-39.6020
-48.9460
-134.2580
-47.7180
-156.7910
Issuance of Capital Stock
16,730.4150
--
27,727.1940
9,408.9200
11,458.4960
Issuance of Debt
--
--
--
--
1,058.7000
Repayment of Debt
--
--
--
-27.8640
-11.8800
Repurchase of Capital Stock
--
--
--
-1.0000
--
Free Cash Flow
-27,239.5080
-25,222.5850
-19,164.4660
-11,244.1380
-2,907.3610
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NLSPW NLS Pharmaceutics AG
0.0162
-6.36%
WSNAF Wesana Health Holdings Inc.
0.0055
0.00%
IMR.F AC Immune SA
2.6050
-1.14%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0280
0.00%
IMTXW Immatics N.V.
0.0900
-43.75%
SRZNW Surrozen, Inc.
0.0500
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0251
0.00%
BV3A.SG Bavarian Nordic A/S
8.80
-1.68%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%